News
Learn about loans against mutual funds, including eligibility, interest rates, and risks before considering this option.
Mutual fund analysis is a critical part of financial strategy and investment planning, helping align the fund's benefits and ...
Investors should consider ICICI Pru’s Pharma Healthcare & Diagnostics Fund for exposure to healthcare amid tariff volatility.
Even as the mutual fund industry celebrates a new all-time high in systematic investment plan (SIP) inflows for June 2025, a ...
A comprehensive recap of the week ending July 11, 2025, highlighting the biggest market movers, top news events, and key ...
Groww, a leading investment platform in India, introduces a new feature. Investors can now hold mutual fund units in demat ...
The shift of Indian investors towards passive investing is perceptible, with the growing interest for ETFs like Nifty 50 and index funds, according to data from AMFI. This surge is driven by a mix of ...
Although it is not readily doable, a corpus of Rs 1 Cr can be reached with a SIP of Rs 6000 each month. An estimated annual ...
Anthem Biosciences raised ₹1,016 crore from anchor investors ahead of its IPO. Major participants included international investment authorities and mutual funds. The firm plans a ₹3,395 crore IPO open ...
FundsIndia appoints Akshay Sapru as its new Group CEO. Sapru brings 27 years of BFSI experience to lead the company's strategic growth.
Your investments should follow the example of a balanced diet—with the right mix of stocks, bonds, gold and other instruments ...
Bengaluru-based Anthem Biosciences has raised ₹1,016.02 crore from 60 institutional investors through its anchor book on July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results